Please login to the form below
heart attack
This page shows the latest heart attack news and features for those working in and with pharma, biotech and healthcare.
CGRP migraine drugs need prior approval for use, recommends ICER
and potential harms”of these new drugs, noting that the FDA has requested additional research into liver toxicity and risks for heart attack and stroke after exposure to erenumab, and into
Latest news
-
NHS could save almost £7bn through its own resources
The report specifically evaluated the savings of three IVD tests - covering suspected heart attacks, pre-eclampsia in pregnancy and diagnosing irritable bowel syndrome (IBS) - if widely used. ... It found that using the high sensitivity cardiac troponin
-
Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?
Amgen’s FOURIER reduced heart attack risks by 27%, stroke risks by 21% and coronary revascularisations by 22%, but didn't provide a mortality benefit. ... Herceptin, which could reduce their risk of heart damage while making significant cost-savings
-
Amgen gets prevention claim for cholesterol drug Repatha
Amgen gets prevention claim for cholesterol drug Repatha. FDA approves new labelling on heart attack and stroke risk reduction. ... The new label is based on the results of the FOURIER trial, which showed that the drug reduced the risk of heart attack by
-
Alcon's return to growth gives Novartis 'options', says CEO
Immunotherapy Cosentyx (secukinumab) for psoriasis, ankylosing spondylitis and psoriatic arthritis rocketed 90% to reach $490m in the quarter, while slow-burner Entresto (sacubitril and valsartan) for heart failure contributed $110m and ... A string of
-
CV data sets up Novartis' Ilaris for blockbuster sales
with a prior heart attack and inflammatory atherosclerosis when added to standard therapy. ... Novartis' chief medical officer Vas Narasimhan is hopeful. "Despite current treatment, about 25% of heart attack survivors will have another cardiovascular
More from news
Approximately 5 fully matching, plus 214 partially matching documents found.
Latest Intelligence
-
Insights from Cannes Lions Health Festival 2018
sea. He describes the impact – the pain, the chaos and the suffering – and we experience the attack with him through Jaws-style shots. ... The film ends with a big reveal: this wasn’t a shark attack, but a heart attack.
-
Proving real-world value
Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”.
-
Why health psychology is the answer to tackling adherence
Therapy (OAP), a treatment that has been shown to reduce the risk of death or non-fatal heart attack.
-
Transforming times at AstraZeneca
She gives the example of a drug to prevent a second heart attack that has a positive NICE recommendation, can save people's lives and reduce further hospital costs. “ ... After a heart attack people tend to leave the hospital thinking the event is over.
-
The rise of chronic disease in BRIC markets
Cardiovascular diseases – such as heart attack, stroke, DVT and atrial fibrillation – also present a major problem in Russia, with 46 per cent of self-reported sufferers (39 per cent being diagnosed). ... Analysts predict that ischaemic heart disease
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018
heart attack to a shark attack out at sea. ... The impactful film is designed to urge cardiologists to keep treating heart attack victims to reduce the risk of often fatal second heart attacks.
-
Health knowledge: Why is it so important?
Smokers know the dangers but smoke anyway, and inactive people know moving more would result in better overall health and less chance of developing a heart condition, but continue to prefer ... We are also more likely to change behaviour in response to
-
Understanding the "Big Picture"
In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
-
Systematic Review Lead- London
-
Negotiable
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Medical Writer
-
Salary is DOE
-
Associate Scientific Director
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Account Manager
-
Negotiable
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- J&J files ‘breakthrough’ bladder cancer drug in US
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- NHS wins legal fight with pharma over off-label Avastin
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Healthcircle
We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
